Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Subunit arrangement and function in NMDA receptors.

Furukawa H, Singh SK, Mancusso R, Gouaux E.

Nature. 2005 Nov 10;438(7065):185-92.

PMID:
16281028
2.

Mechanism of positive allosteric modulators acting on AMPA receptors.

Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E, Partin KM.

J Neurosci. 2005 Sep 28;25(39):9027-36.

3.

Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.

Porrino LJ, Daunais JB, Rogers GA, Hampson RE, Deadwyler SA.

PLoS Biol. 2005 Sep;3(9):e299. Epub 2005 Aug 23.

4.

Stargazin modulates AMPA receptor gating and trafficking by distinct domains.

Tomita S, Adesnik H, Sekiguchi M, Zhang W, Wada K, Howe JR, Nicoll RA, Bredt DS.

Nature. 2005 Jun 23;435(7045):1052-8. Epub 2005 Apr 27.

5.

Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors.

Priel A, Kolleker A, Ayalon G, Gillor M, Osten P, Stern-Bach Y.

J Neurosci. 2005 Mar 9;25(10):2682-6.

6.

Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses.

Tomita S, Fukata M, Nicoll RA, Bredt DS.

Science. 2004 Mar 5;303(5663):1508-11.

7.

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P.

Eur J Pharmacol. 2004 Feb 20;486(2):163-74.

PMID:
14975705
8.

AMPA receptor trafficking at excitatory synapses.

Bredt DS, Nicoll RA.

Neuron. 2003 Oct 9;40(2):361-79. Review.

9.

Stargazin differentially controls the trafficking of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate and kainate receptors.

Chen L, El-Husseini A, Tomita S, Bredt DS, Nicoll RA.

Mol Pharmacol. 2003 Sep;64(3):703-6.

10.

Enhancement of antidepressant potency by a potentiator of AMPA receptors.

Li X, Witkin JM, Need AB, Skolnick P.

Cell Mol Neurobiol. 2003 Jun;23(3):419-30.

PMID:
12825836
11.

Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins.

Tomita S, Chen L, Kawasaki Y, Petralia RS, Wenthold RJ, Nicoll RA, Bredt DS.

J Cell Biol. 2003 May 26;161(4):805-16.

12.

A desensitization-selective potentiator of AMPA-type glutamate receptors.

Sekiguchi M, Nishikawa K, Aoki S, Wada K.

Br J Pharmacol. 2002 Aug;136(7):1033-41.

13.

Mechanism of glutamate receptor desensitization.

Sun Y, Olson R, Horning M, Armstrong N, Mayer M, Gouaux E.

Nature. 2002 May 16;417(6886):245-53.

PMID:
12015593
14.

The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment.

Sekiguchi M, Yamada K, Jin J, Hachitanda M, Murata Y, Namura S, Kamichi S, Kimura I, Wada K.

Neuroreport. 2001 Sep 17;12(13):2947-50.

PMID:
11588608
15.
16.
17.

A novel allosteric potentiator of AMPA receptors: 4--2-(phenylsulfonylamino)ethylthio--2,6-difluoro-phenoxyaceta mide.

Sekiguchi M, Fleck MW, Mayer ML, Takeo J, Chiba Y, Yamashita S, Wada K.

J Neurosci. 1997 Aug 1;17(15):5760-71.

18.

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

Lynch G, Granger R, Ambros-Ingerson J, Davis CM, Kessler M, Schehr R.

Exp Neurol. 1997 May;145(1):89-92.

PMID:
9184112
20.

AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide.

Fleck MW, Bähring R, Patneau DK, Mayer ML.

J Neurophysiol. 1996 Jun;75(6):2322-33.

PMID:
8793745
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk